Publications by authors named "Alice Rudolph"

Claim this Profile
E
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.

JAMA· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial.
Michael A Schwarzschild, Eric A Macklin, Rachit Bakshi, Shamik Battacharyya, Robert Logan, Alice Rudolph

Neurology· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
Un Jung Kang, Jennifer G Goldman, Roy N Alcalay, Tao Xie, Paul Tuite, Alice Rudolph

Mov Disord· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.

JAMA Neurol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
Connie Marras, Michael P McDermott, Ken Marek, Paula Rochon, Gary Naglie, Alice Rudolph

Mov Disord· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
Steven R Schwid, Janice Bausch, David Oakes, Lynn Schuchter, Caroline Tanner, Alice Rudolph

Mov Disord· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.
David K Simon, Nathan Pankratz, Diane K Kissell, Michael W Pauciulo, Cheryl A Halter, Alice Rudolph

BMC Med Genet· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urate as a predictor of the rate of clinical decline in Parkinson disease.
Alberto Ascherio, Peter A LeWitt, Kui Xu, Shirley Eberly, Arthur Watts, Alice Rudolph

Arch Neurol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-synuclein and familial Parkinson's disease.
Nathan Pankratz, William C Nichols, Veronika E Elsaesser, Michael W Pauciulo, Diane K Marek, Alice Rudolph

Mov Disord· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical correlates of depressive symptoms in familial Parkinson's disease.
Nathan Pankratz, Karen S Marder, Cheryl A Halter, Alice Rudolph, Cliff W Shults

Mov Disord· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
Michael A Schwarzschild, Steven R Schwid, Kenneth Marek, Arthur Watts, Anthony E Lang, Alice Rudolph

Arch Neurol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation.
William C Nichols, Diane K Marek, Michael W Pauciulo, Nathan Pankratz, Cheryl A Halter, Alice Rudolph

Mov Disord· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
Nathan Pankratz, Michael W Pauciulo, Veronika E Elsaesser, Diane K Marek, Cheryl A Halter, Alice Rudolph

Mov Disord· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in DJ-1 are rare in familial Parkinson disease.
Nathan Pankratz, Michael W Pauciulo, Veronika E Elsaesser, Diane K Marek, Cheryl A Halter, Alice Rudolph

Neurosci Lett· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Nathan Pankratz, Lisa Byder, Cheryl Halter, Alice Rudolph, Clifford W Shults

Mov Disord· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
William C Nichols, Nathan Pankratz, Dena Hernandez, Coro Paisán-Ruíz, Shushant Jain, Alice Rudolph

Lancet· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa and the progression of Parkinson's disease.
Stanley Fahn, David Oakes, Ira Shoulson, Karl Kieburtz, Alice Rudolph

N Engl J Med· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease.
William C Nichols, Sean K Uniacke, Nathan Pankratz, Terry Reed, David K Simon, Alice Rudolph

Mov Disord· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.
Nathan Pankratz, William C Nichols, Sean K Uniacke, Cheryl Halter, Jill Murrell, Alice Rudolph

Hum Mol Genet· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant linkage of Parkinson disease to chromosome 2q36-37.
Nathan Pankratz, William C Nichols, Sean K Uniacke, Cheryl Halter, Alice Rudolph

Am J Hum Genet· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.
Nathan Pankratz, William C Nichols, Sean K Uniacke, Cheryl Halter, Alice Rudolph

Am J Hum Genet· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
Ira Shoulson, David Oakes, Stanley Fahn, Anthony Lang, J William Langston, Alice Rudolph

Ann Neurol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis